Novel Cyclic Lipopeptide Antibiotics: Effects of Acyl Chain Length and Position

Multidrug-resistant bacteria are a global health problem. One of the last-resort antibiotics against Gram-negative bacteria is the cyclic lipopeptide colistin, displaying a flexible linker with a fatty acid moiety. The aim of the present project was to investigate the effect on antimicrobial activit...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 21; no. 16; p. 5829
Main Authors Jensen, Signe Kaustrup, Thomsen, Thomas T, Oddo, Alberto, Franzyk, Henrik, Løbner-Olesen, Anders, Hansen, Paul R
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 13.08.2020
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Multidrug-resistant bacteria are a global health problem. One of the last-resort antibiotics against Gram-negative bacteria is the cyclic lipopeptide colistin, displaying a flexible linker with a fatty acid moiety. The aim of the present project was to investigate the effect on antimicrobial activity of introducing fatty acid moieties of different lengths and in different positions in a cyclic peptide, S3(B), containing a flexible linker. The lipidated analogues of S3(B) were synthesized by 9-fluorenylmethoxycarbonyl (Fmoc) solid-phase peptide synthesis. Following assembly of the linear peptide by Fmoc solid-phase peptide synthesis, on-resin head-to-tail cyclization and fatty acid acylation were performed. The antimicrobial activity was determined against the ESKAPE pathogens, , , , , and . Furthermore, hemolytic activity was determined against human erythrocytes. A total of 18 cyclic lipopeptides were synthesized and characterized. It was found that introduction of fatty acids in positions next to the flexible linker was more strongly linked to antimicrobial activity. The fatty acid length altered the overall hydrophobicity, which was the driving force for both high antimicrobial and hemolytic activity. Peptides became highly hemolytic when carbon-chain length exceeded 10 (i.e., C ), overlapping with the optimum for antimicrobial activity (i.e., C -C ). The most promising candidate (C ) showed antimicrobial activity corresponding to that of S3(B), but with an improved hemolytic profile. Finally, (C ) was further investigated in a time-kill experiment.
AbstractList Multidrug-resistant bacteria are a global health problem. One of the last-resort antibiotics against Gram-negative bacteria is the cyclic lipopeptide colistin, displaying a flexible linker with a fatty acid moiety. The aim of the present project was to investigate the effect on antimicrobial activity of introducing fatty acid moieties of different lengths and in different positions in a cyclic peptide, S3(B), containing a flexible linker. The lipidated analogues of S3(B) were synthesized by 9-fluorenylmethoxycarbonyl (Fmoc) solid-phase peptide synthesis. Following assembly of the linear peptide by Fmoc solid-phase peptide synthesis, on-resin head-to-tail cyclization and fatty acid acylation were performed. The antimicrobial activity was determined against the ESKAPE pathogens, , , , , and . Furthermore, hemolytic activity was determined against human erythrocytes. A total of 18 cyclic lipopeptides were synthesized and characterized. It was found that introduction of fatty acids in positions next to the flexible linker was more strongly linked to antimicrobial activity. The fatty acid length altered the overall hydrophobicity, which was the driving force for both high antimicrobial and hemolytic activity. Peptides became highly hemolytic when carbon-chain length exceeded 10 (i.e., C ), overlapping with the optimum for antimicrobial activity (i.e., C -C ). The most promising candidate (C ) showed antimicrobial activity corresponding to that of S3(B), but with an improved hemolytic profile. Finally, (C ) was further investigated in a time-kill experiment.
Multidrug-resistant bacteria are a global health problem. One of the last-resort antibiotics against Gram-negative bacteria is the cyclic lipopeptide colistin, displaying a flexible linker with a fatty acid moiety. The aim of the present project was to investigate the effect on antimicrobial activity of introducing fatty acid moieties of different lengths and in different positions in a cyclic peptide, S3(B), containing a flexible linker. The lipidated analogues of S3(B) were synthesized by 9-fluorenylmethoxycarbonyl (Fmoc) solid-phase peptide synthesis. Following assembly of the linear peptide by Fmoc solid-phase peptide synthesis, on-resin head-to-tail cyclization and fatty acid acylation were performed. The antimicrobial activity was determined against the ESKAPE pathogens, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Escherichia coli. Furthermore, hemolytic activity was determined against human erythrocytes. A total of 18 cyclic lipopeptides were synthesized and characterized. It was found that introduction of fatty acids in positions next to the flexible linker was more strongly linked to antimicrobial activity. The fatty acid length altered the overall hydrophobicity, which was the driving force for both high antimicrobial and hemolytic activity. Peptides became highly hemolytic when carbon-chain length exceeded 10 (i.e., C10), overlapping with the optimum for antimicrobial activity (i.e., C8–C12). The most promising candidate (C8)5 showed antimicrobial activity corresponding to that of S3(B), but with an improved hemolytic profile. Finally, (C8)5 was further investigated in a time-kill experiment.
Multidrug-resistant bacteria are a global health problem. One of the last-resort antibiotics against Gram-negative bacteria is the cyclic lipopeptide colistin, displaying a flexible linker with a fatty acid moiety. The aim of the present project was to investigate the effect on antimicrobial activity of introducing fatty acid moieties of different lengths and in different positions in a cyclic peptide, S3(B), containing a flexible linker. The lipidated analogues of S3(B) were synthesized by 9-fluorenylmethoxycarbonyl (Fmoc) solid-phase peptide synthesis. Following assembly of the linear peptide by Fmoc solid-phase peptide synthesis, on-resin head-to-tail cyclization and fatty acid acylation were performed. The antimicrobial activity was determined against the ESKAPE pathogens, Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , Pseudomonas aeruginosa , and Escherichia coli . Furthermore, hemolytic activity was determined against human erythrocytes. A total of 18 cyclic lipopeptides were synthesized and characterized. It was found that introduction of fatty acids in positions next to the flexible linker was more strongly linked to antimicrobial activity. The fatty acid length altered the overall hydrophobicity, which was the driving force for both high antimicrobial and hemolytic activity. Peptides became highly hemolytic when carbon-chain length exceeded 10 (i.e., C 10 ), overlapping with the optimum for antimicrobial activity (i.e., C 8 –C 12 ). The most promising candidate (C 8 ) 5 showed antimicrobial activity corresponding to that of S3(B), but with an improved hemolytic profile. Finally, (C 8 ) 5 was further investigated in a time-kill experiment.
Author Jensen, Signe Kaustrup
Hansen, Paul R
Thomsen, Thomas T
Oddo, Alberto
Franzyk, Henrik
Løbner-Olesen, Anders
AuthorAffiliation 2 Department of Clinical Microbiology, Rigshospitalet, Henrik HarpestrengsVej 4A, 2100 Copenhagen, Denmark; thomas.thomsen@bio.ku.dk
3 Department of Biology, Section for Functional Genomics, University of Copenhagen, Ole MaaløesVej 5, 2200 Copenhagen, Denmark; lobner@bio.ku.dk
1 Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark; signekaustrupjensen@outlook.com (S.K.J.); albi.oddo@gmail.com (A.O.); henrik.franzyk@sund.ku.dk (H.F.)
AuthorAffiliation_xml – name: 1 Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark; signekaustrupjensen@outlook.com (S.K.J.); albi.oddo@gmail.com (A.O.); henrik.franzyk@sund.ku.dk (H.F.)
– name: 3 Department of Biology, Section for Functional Genomics, University of Copenhagen, Ole MaaløesVej 5, 2200 Copenhagen, Denmark; lobner@bio.ku.dk
– name: 2 Department of Clinical Microbiology, Rigshospitalet, Henrik HarpestrengsVej 4A, 2100 Copenhagen, Denmark; thomas.thomsen@bio.ku.dk
Author_xml – sequence: 1
  givenname: Signe Kaustrup
  surname: Jensen
  fullname: Jensen, Signe Kaustrup
  organization: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark
– sequence: 2
  givenname: Thomas T
  orcidid: 0000-0003-3130-2784
  surname: Thomsen
  fullname: Thomsen, Thomas T
  organization: Department of Biology, Section for Functional Genomics, University of Copenhagen, Ole MaaløesVej 5, 2200 Copenhagen, Denmark
– sequence: 3
  givenname: Alberto
  orcidid: 0000-0002-5759-9988
  surname: Oddo
  fullname: Oddo, Alberto
  organization: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark
– sequence: 4
  givenname: Henrik
  orcidid: 0000-0002-2822-1927
  surname: Franzyk
  fullname: Franzyk, Henrik
  organization: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark
– sequence: 5
  givenname: Anders
  orcidid: 0000-0002-0344-6417
  surname: Løbner-Olesen
  fullname: Løbner-Olesen, Anders
  organization: Department of Biology, Section for Functional Genomics, University of Copenhagen, Ole MaaløesVej 5, 2200 Copenhagen, Denmark
– sequence: 6
  givenname: Paul R
  orcidid: 0000-0001-9357-8001
  surname: Hansen
  fullname: Hansen, Paul R
  organization: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, 2100 Copenhagen, Denmark
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32823798$$D View this record in MEDLINE/PubMed
BookMark eNpVkUtvUzEQhS1URB-wY40ssSVgj-_1gwVSFBWoFFEWsLYcPxJHN_bFdirl33NDSpWuZjRz9M0ZnWt0kXLyCL2l5CNjinyK210FSnkvQb1AV7QDmBHCxcVZf4mua90SAgx69QpdMpDAhJJX6P5HfvADXhzsEC1exjGPfmzReTxPLa5ibtHWz_g2BG9bxTnguT1M-o2JCS99WrcNNsnhn7nGFnN6jV4GM1T_5rHeoN9fb38tvs-W99_uFvPlzHZCthnzLHjnDBFCKcm7HjidjErJwHPDVsqAtQFob5RzDIjx3kmQHBzhwUjObtDdieuy2eqxxJ0pB51N1P8Guay1KZP3wWvJLfOUA7Oy70iwCqgIgvWccOs6dWR9ObHG_WrnnfWpFTM8gz7fpLjR6_ygRcdpz-UEeP8IKPnP3temt3lf0vS_ho71hFAujmc-nFS25FqLD08XKNHHKPV5lJP83bmrJ_H_7Nhfkw2axA
CitedBy_id crossref_primary_10_1002_psc_3560
crossref_primary_10_1016_j_ejmcr_2022_100080
crossref_primary_10_3390_ijms21249552
crossref_primary_10_1016_j_foodchem_2024_139119
crossref_primary_10_3390_ijms241914801
crossref_primary_10_1039_D1TB02852A
crossref_primary_10_3390_ijms24065505
crossref_primary_10_3390_ph16030439
crossref_primary_10_1016_j_biotechadv_2023_108210
crossref_primary_10_1016_j_ijbiomac_2023_124884
crossref_primary_10_4155_fmc_2022_0160
crossref_primary_10_1016_j_ejmech_2024_116337
crossref_primary_10_1016_j_molstruc_2022_133382
crossref_primary_10_1021_acs_bioconjchem_2c00519
crossref_primary_10_3390_antibiotics11081080
Cites_doi 10.1038/ja.2013.111
10.1016/S0005-2736(99)00198-4
10.1016/j.cbpa.2017.02.006
10.1371/journal.pone.0071151
10.1080/00304948.2016.1127096
10.3390/antibiotics9010024
10.3389/fmicb.2019.00539
10.3390/antibiotics9070366
10.1002/(SICI)1097-0282(1997)43:1<15::AID-BIP3>3.0.CO;2-3
10.1021/cb4006613
10.1016/j.jcis.2009.11.057
10.1128/AAC.00925-06
10.1038/415389a
10.1007/978-1-4939-6737-7
10.1038/s41579-019-0288-0
10.3389/fmicb.2019.01689
10.1007/978-1-4939-6737-7_31
10.1016/j.mib.2017.10.028
10.1038/s41573-019-0058-8
10.1046/j.1432-1033.2001.02494.x
10.1128/AAC.01966-15
10.1038/nprot.2007.521
10.1086/429323
10.3390/molecules22091430
10.3109/07388551.2011.594423
10.1016/S0014-5793(01)02648-5
10.3390/molecules24183314
10.1021/cb500080r
10.1110/ps.072966007
10.1128/AAC.02340-16
10.1021/bi00892a002
ContentType Journal Article
Copyright 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2020 by the authors. 2020
Copyright_xml – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2020 by the authors. 2020
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
M0S
M1P
M2O
MBDVC
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
5PM
DOA
DOI 10.3390/ijms21165829
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest research library
Research Library (Corporate)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Research Library
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList MEDLINE
Publicly Available Content Database

CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1422-0067
ExternalDocumentID oai_doaj_org_article_86c3e1623c8540fc9217f735606cd496
10_3390_ijms21165829
32823798
Genre Journal Article
GroupedDBID ---
29J
2WC
3V.
53G
5GY
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
8G5
A8Z
AADQD
AAFWJ
ABDBF
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ADBBV
AEAQA
AENEX
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CGR
CS3
CUY
CVF
D1I
DIK
DU5
DWQXO
E3Z
EBD
EBS
ECM
EIF
EJD
ESTFP
ESX
F5P
FRP
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
KB.
KQ8
LK8
M1P
M2O
M48
M7P
MODMG
M~E
NPM
O5R
O5S
OK1
P2P
PDBOC
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RNS
RPM
TR2
TUS
UKHRP
~8M
AAHBH
AAYXX
ALIPV
CITATION
7XB
8FK
ITC
K9.
MBDVC
PQEST
PQUKI
PRINS
Q9U
5PM
ID FETCH-LOGICAL-c478t-3e3fedda0779986452610068832e6a3b9a2ccf215a9dd320aeed82862d06fa863
IEDL.DBID RPM
ISSN 1422-0067
1661-6596
IngestDate Fri Jul 05 11:49:44 EDT 2024
Tue Sep 17 21:27:49 EDT 2024
Tue Sep 24 21:20:43 EDT 2024
Fri Aug 23 04:57:51 EDT 2024
Thu May 23 23:41:02 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 16
Keywords fatty acid
hydrophobicity
cyclic lipopeptides
antimicrobial peptides
colistin
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c478t-3e3fedda0779986452610068832e6a3b9a2ccf215a9dd320aeed82862d06fa863
Notes Current address: Novo Nordisk A/S, Krogshøjvej 44, 2820 Bagsværd, Denmark.
ORCID 0000-0002-5759-9988
0000-0002-0344-6417
0000-0002-2822-1927
0000-0001-9357-8001
0000-0003-3130-2784
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461568/
PMID 32823798
PQID 2435001676
PQPubID 2032341
ParticipantIDs doaj_primary_oai_doaj_org_article_86c3e1623c8540fc9217f735606cd496
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7461568
proquest_journals_2435001676
crossref_primary_10_3390_ijms21165829
pubmed_primary_32823798
PublicationCentury 2000
PublicationDate 20200813
PublicationDateYYYYMMDD 2020-08-13
PublicationDate_xml – month: 8
  year: 2020
  text: 20200813
  day: 13
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle International journal of molecular sciences
PublicationTitleAlternate Int J Mol Sci
PublicationYear 2020
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Howard (ref_21) 2016; 48
Falagas (ref_16) 2005; 40
ref_14
ref_13
ref_11
ref_32
Oddo (ref_33) 2016; 60
Zorzi (ref_15) 2017; 38
Epand (ref_30) 1997; 43
Nielsen (ref_22) 2007; 16
Theuretzbacher (ref_4) 2020; 18
ref_18
ref_17
Vaara (ref_19) 2019; 10
Deris (ref_12) 2014; 67
Cleland (ref_23) 1964; 3
Chen (ref_28) 2007; 51
Epand (ref_10) 1999; 1462
Velkov (ref_20) 2014; 9
Zasloff (ref_6) 2002; 415
Li (ref_25) 2014; 9
Dathe (ref_27) 2001; 501
Wiegand (ref_24) 2008; 3
Oddo (ref_31) 2017; 1548
Nguyen (ref_29) 2010; 345
Mulani (ref_2) 2019; 10
Theuretzbacher (ref_1) 2017; 39
ref_3
Pasupuleti (ref_9) 2012; 32
Giangaspero (ref_26) 2001; 268
ref_8
ref_5
Mookherjee (ref_7) 2020; 19
References_xml – volume: 67
  start-page: 147
  year: 2014
  ident: ref_12
  article-title: A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity
  publication-title: J. Antibiot. (Tokyo)
  doi: 10.1038/ja.2013.111
  contributor:
    fullname: Deris
– volume: 1462
  start-page: 11
  year: 1999
  ident: ref_10
  article-title: Diversity of antimicrobial peptides and their mechanisms of action
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/S0005-2736(99)00198-4
  contributor:
    fullname: Epand
– volume: 38
  start-page: 24
  year: 2017
  ident: ref_15
  article-title: Cyclic peptide therapeutics: Past, present and future
  publication-title: Curr. Opin. Chem. Biol.
  doi: 10.1016/j.cbpa.2017.02.006
  contributor:
    fullname: Zorzi
– ident: ref_17
  doi: 10.1371/journal.pone.0071151
– volume: 48
  start-page: 1
  year: 2016
  ident: ref_21
  article-title: Preparation and Applications of 4-Methoxybenzyl Esters in Organic Synthesis
  publication-title: Org. Prep. Proced. Int.
  doi: 10.1080/00304948.2016.1127096
  contributor:
    fullname: Howard
– ident: ref_32
– ident: ref_3
– ident: ref_13
  doi: 10.3390/antibiotics9010024
– volume: 10
  start-page: 539
  year: 2019
  ident: ref_2
  article-title: Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2019.00539
  contributor:
    fullname: Mulani
– ident: ref_18
  doi: 10.3390/antibiotics9070366
– volume: 43
  start-page: 15
  year: 1997
  ident: ref_30
  article-title: Biophysical studies of lipopeptide-membrane interactions
  publication-title: Biopolymers
  doi: 10.1002/(SICI)1097-0282(1997)43:1<15::AID-BIP3>3.0.CO;2-3
  contributor:
    fullname: Epand
– volume: 9
  start-page: 211
  year: 2014
  ident: ref_25
  article-title: Lipidated Cyclic gamma-AApeptides Display Both Antimicrobial and Anti-inflammatory Activity
  publication-title: ACS Chem. Biol.
  doi: 10.1021/cb4006613
  contributor:
    fullname: Li
– volume: 345
  start-page: 160
  year: 2010
  ident: ref_29
  article-title: Chain length dependence of antimicrobial peptide–fatty acid conjugate activity
  publication-title: J. Colloid Interface Sci.
  doi: 10.1016/j.jcis.2009.11.057
  contributor:
    fullname: Nguyen
– volume: 51
  start-page: 1398
  year: 2007
  ident: ref_28
  article-title: Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.00925-06
  contributor:
    fullname: Chen
– volume: 415
  start-page: 389
  year: 2002
  ident: ref_6
  article-title: Antimicrobial peptides of multicellular organisms
  publication-title: Nature
  doi: 10.1038/415389a
  contributor:
    fullname: Zasloff
– ident: ref_8
  doi: 10.1007/978-1-4939-6737-7
– volume: 18
  start-page: 275
  year: 2020
  ident: ref_4
  article-title: The global preclinical antibacterial pipeline
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/s41579-019-0288-0
  contributor:
    fullname: Theuretzbacher
– volume: 10
  start-page: 1689
  year: 2019
  ident: ref_19
  article-title: Polymyxins and Their Potential Next Generation as Therapeutic Antibiotics
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2019.01689
  contributor:
    fullname: Vaara
– volume: 1548
  start-page: 427
  year: 2017
  ident: ref_31
  article-title: Hemolytic Activity of Antimicrobial Peptides
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-4939-6737-7_31
  contributor:
    fullname: Oddo
– volume: 39
  start-page: 106
  year: 2017
  ident: ref_1
  article-title: Global antimicrobial resistance in Gram-negative pathogens and clinical need
  publication-title: Curr. Opin. Microbiol.
  doi: 10.1016/j.mib.2017.10.028
  contributor:
    fullname: Theuretzbacher
– volume: 19
  start-page: 311
  year: 2020
  ident: ref_7
  article-title: Antimicrobial host defence peptides: Functions and clinical potential
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/s41573-019-0058-8
  contributor:
    fullname: Mookherjee
– volume: 268
  start-page: 5589
  year: 2001
  ident: ref_26
  article-title: Amphipathic α helical antimicrobial peptides
  publication-title: Eur. J. Biochem.
  doi: 10.1046/j.1432-1033.2001.02494.x
  contributor:
    fullname: Giangaspero
– volume: 60
  start-page: 592
  year: 2016
  ident: ref_33
  article-title: An all-D amphipathic undecapeptide shows promising activity against colistin-resistant strains of Acinetobacter baumannii and a dual mode of action
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.01966-15
  contributor:
    fullname: Oddo
– volume: 3
  start-page: 163
  year: 2008
  ident: ref_24
  article-title: Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2007.521
  contributor:
    fullname: Wiegand
– volume: 40
  start-page: 1333
  year: 2005
  ident: ref_16
  article-title: Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
  publication-title: Clin. Infect. Dis.
  doi: 10.1086/429323
  contributor:
    fullname: Falagas
– ident: ref_14
  doi: 10.3390/molecules22091430
– volume: 32
  start-page: 143
  year: 2012
  ident: ref_9
  article-title: Antimicrobial peptides: Key components of the innate immune system
  publication-title: Crit. Rev. Biotechnol.
  doi: 10.3109/07388551.2011.594423
  contributor:
    fullname: Pasupuleti
– volume: 501
  start-page: 146
  year: 2001
  ident: ref_27
  article-title: Optimization of the antimicrobial activity of magainin peptides by modification of charge
  publication-title: FEBS Lett.
  doi: 10.1016/S0014-5793(01)02648-5
  contributor:
    fullname: Dathe
– ident: ref_5
  doi: 10.3390/molecules24183314
– volume: 9
  start-page: 1172
  year: 2014
  ident: ref_20
  article-title: Teaching ‘Old’ Polymyxins New Tricks: New-Generation Lipopeptides Targeting Gram-Negative ‘Superbugs’
  publication-title: ACS Chem. Biol.
  doi: 10.1021/cb500080r
  contributor:
    fullname: Velkov
– volume: 16
  start-page: 1969
  year: 2007
  ident: ref_22
  article-title: Structure activity study of the antibacterial peptide fallaxin
  publication-title: Protein Sci.
  doi: 10.1110/ps.072966007
  contributor:
    fullname: Nielsen
– ident: ref_11
  doi: 10.1128/AAC.02340-16
– volume: 3
  start-page: 480
  year: 1964
  ident: ref_23
  article-title: Dithiothreitol, a New Protective Reagent for SH Groups
  publication-title: Biochemistry
  doi: 10.1021/bi00892a002
  contributor:
    fullname: Cleland
SSID ssj0023259
Score 2.4080548
Snippet Multidrug-resistant bacteria are a global health problem. One of the last-resort antibiotics against Gram-negative bacteria is the cyclic lipopeptide colistin,...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 5829
SubjectTerms Acylation
Anti-Bacterial Agents - chemical synthesis
Anti-Bacterial Agents - chemistry
Anti-Bacterial Agents - pharmacology
Antibiotics
Antiinfectives and antibacterials
Antimicrobial activity
Antimicrobial agents
antimicrobial peptides
Bacteria
Colistin
cyclic lipopeptides
Cyclization
Erythrocytes
fatty acid
Fatty acids
Fatty Acids - chemistry
Gram-negative bacteria
Gram-positive bacteria
Hemolysis - drug effects
Hydrophobic and Hydrophilic Interactions
Hydrophobicity
Klebsiella
Lipopeptides
Lipopeptides - chemical synthesis
Lipopeptides - chemistry
Lipopeptides - pharmacology
Microbial Sensitivity Tests
Molecular weight
Multidrug resistance
Pathogens
Peptide synthesis
Peptides
Pseudomonas aeruginosa
Pseudomonas aeruginosa - drug effects
Solid phases
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NSwMxEA0iCF7Eb6tVctDjYptsk423WiwiWj1Y8Lak-bArultsFfrvndlsayuCF6-bwA4zG96bzcwbQk6ZtExLwyIf4zUja8RRYrmL9ECD3RJAt5w8d9cT1_345qn1tDDqC2vCgjxwcNx5Igx3TQBpkwC58EYBh_aSA1ALY2MVxLabrVkyVaVanJVj0pqAPpFoKRFK3jkk-OfZy9uYoehMUtLKbzAqNft_I5o_6yUXAKi7STYq5kjbweItsuLybbIWZklOd8h9r_h0r7QzNa-ZobfZqBhhwYp1tJ1jX0iBeswXNKgVj2nhadtMYf9QZzm9dfnzZEh1bulDVcW1S_rdq8fOdVRNS4hMLJNJxB33zlrdkFKh5noLciNsAIEj64TmA6WZMR4QXitrOWtoQEfsIWe2IbxOBN8jq3mRuwNCrfR4G-c50yoeOBxGhj-ImPFaCOVNjZzN3JaOgihGCskEujdddG-NXKJP53tQyrp8AAFOqwCnfwW4RuqziKTV-RqnDFhe2UEBy_shOPO3cIYCPCqpEbkUtiUzllfybFgqa8sYCJ5IDv_D7iOyzjA3R_lcXierk_cPdwwEZjI4Kb_VL9Cc6q0
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT9swED8x0KS9TMC-Mj7kB_YYtbVTO94LKghUIejQNCTeIscfNBNLOppN6n-_uyQtdEK8JpZs3dm-3_nufgdwxJXjRlkeh4TCjLyfxKkTPja5wXUrNLpN57mriRzfJBe3w9sNGC9rYSitcnknNhe1qyy9kfc42vUmZ172TE6vALbuHc9-x9Q_iuKsXTONV7DFBwkFbLdOzibX31fOl-BN47QB2qNYDrVsk-AFuvy94uevOScamrQBmo_mqWHxfw56_p9B-cQknW_D2w5LslGr_B3Y8OUuvG67Sy7ewbdJ9dffs9OFvS8suyxm1YxSWJxno5IqRSpiaP7KWv7iOasCG9kFjp-aomSXvryrp8yUjl13eV3v4eb87MfpOO76J8Q2UWkdCy-Cd870ldLEwj5Eb4lKQvAQe2lErg23NqDNN9o5wfsG7SVVlXPXl8GkUnyAzbIq_SdgTgWKzwXBjU5yT-3J6MmI22Ck1MFG8GUptmzW0mRk6F6QeLOn4o3ghGS6GkPk1s2H6uEu685Klkor_ABxmU0RTwar0W0KSiA2k9YlWkawv9RI1p24efa4PyL42CpnNYvgRMmj0wjUmtrWlrH-pyymDde2ShDyyfTzy1PuwRtOfjhR5Yp92Kwf_vgDBCt1ftjtw39I6uiH
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwEB4BVSUuCEofy0s-lGPoYnvtGKmqtgiEKl4HVuIWef1gUy0J7C6I_fedSbIrtuXYa-wozoyd-b7Y8w3AV649t9rxJEraZuRtmaRehMT2LY5bY9CtKs9dXKqznvx127ldglm10caA4zepHdWT6o2GBy-P0x-44L8T40TK_i3_fT_mJCOTcrMM77gUkub6hZzvJyBsqMqmHWI0SlTHqPoI_D93LwSnSsP_LeD59_nJVwHpdB3WGiTJurXrN2ApFB_gfV1bcroJV5flcxiy46kb5o6d5w_4Xvh58IF1C8oTKUmf-YjV6sVjVkbWdVPsP7B5wc5DcTcZMFt4dt2c6voIvdOTm-OzpKmekDip00kigojBe9vW2pAGewe5EiWE4BIOyoq-sdy5iBHfGu8Fb1uMlpRTzn1bRZsq8QlWirIIX4B5HWl3LgpujewHKk5GP4y4i1YpE10L9mdmyx5qkYwMyQWZN3tt3hb8JJvO-5C0dXWhHN1lzUrJUuVEOERU5lJEk9EZJE1RC0RmynlpVAt2Zh7JZtMlQ593qowKbP5cO2f-FMFJkMekLdALblsYxmJLkQ8qpW0tEfCpdOt_jHsbVjlxdZLTFTuwMhk9hV0ENJP-XjVX_wAt8_KN
  priority: 102
  providerName: Scholars Portal
Title Novel Cyclic Lipopeptide Antibiotics: Effects of Acyl Chain Length and Position
URI https://www.ncbi.nlm.nih.gov/pubmed/32823798
https://www.proquest.com/docview/2435001676/abstract/
https://pubmed.ncbi.nlm.nih.gov/PMC7461568
https://doaj.org/article/86c3e1623c8540fc9217f735606cd496
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe2ISReEN8URuQHeMxa7NR2eOuqlQmtpUJM6lvk-GPN1DrVWpD633PnJNOKeOLFD7GjWHdn3f3iu98R8pFJy7Q0LPUZXjOyQZYqy12qSw37luB0Y-e56UxcXmffFsPFERl2tTAxad-U1VlYrc9CtYy5lZu16Xd5Yv35dCwz8MNC9Y_JseS8g-gtyuIQ0DcZ7hzwfL-6XW8ZcswohgyhnCE7S64O3FBk6_9XiPl3puQD1zN5Rp62MSMdNXt7To5ceEEeN10k9y_J91n9263oeG9WlaFX1abeYKqKdXQUsCKkRibmL7ThKd7S2tOR2cP6pa4CvXLhZrekOlg6b_O3XpHrycXP8WXa9klITSbVLuWOe2etHkiZI9v6EFARln7AYXVC8zLXzBgPvl3n1nI20OAXsXqc2YHwWgn-mpyEOri3hFrp8R7Oc6bzrHTYhgx_DTHjtRC5Nz3yqRNbsWnoMAqAESjp4qGke-QcZXq_Bkms44P67qZoVVkoYbj7DPGXURA3epMDPPKSQwwmjM1y0SOnnUaK9mRtCwbxXaydgOk3jXLuv9Ipt0fkgdoOtnE4AyYWObVbk3r332--J08YQnFky-Wn5GR398t9gHhlVyZgpQsJo5p8Tcij84vZ_EcSsX-CfmQI4zRTSbTiP2Iv8Lw
link.rule.ids 230,315,733,786,790,870,891,2115,2236,12083,12792,21416,24346,27957,27958,31754,33408,33779,43345,43635,43840,53827,53829,74102,74392,74659
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NbxMxEB1BEYILKp9dKOADHFdNbcdec0FpRRUgDRxaKbeV449mUbsbmoCUf8-Md9M0CHHdtWRrxva8sZ_fALzj2nOrHc-jpGtG3pN54UXI7dTiuDUG3VR57nSshufyy6Q_6Q7cFh2tcr0npo3aN47OyA84xvXEmVcf5z9zqhpFt6tdCY27cE8KIYnSpyebhEvwVCztEGNQrvpGtcR3gWn-QfXjasFJeqZI4HITkpJy_7_g5t-syVth6GQXHnX4kQ1ahz-GO6F-AvfbipKrp_Bt3PwOl-x45S4rx0bVvJkTbcUHNqjpdUhDqswfWKtZvGBNZAO3wvYzW9VsFOqL5YzZ2rPvHZfrGZyffDo7HuZdzYTcSV0scxFEDN7bntaGlNf7mCHRMxBcuEFZMTWWOxcxzlvjveA9izGSXpJz31PRFko8h526qcMeMK8j3clFwa2R00AlyeiYiLtolTLRZfB-bbZy3kpjlJhSkHnL2-bN4IhsetOGBK3Th-b6ouzWR1koJ8IhYjFXIIaMzmCqFLVAPKacl0ZlsL_2SNmtskW5mRMZvGidc9OL4CTDY4oM9Jbbtoax_aeuZklfW0uEeap4-f8u38KD4dnpqBx9Hn99BQ855eEklSv2YWd5_Su8RrCynL5JM_IPKxTmVA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NbxMxEB1BEagXVD67UMAHOK6ytTf2mgtKC1GBEHqgUm4rxx_NonY3bQJS_j0z3k3TIMR115KtGdvzxn5-A_CWK8eNsjwNOV0z8ixPCyd8aqYGx60w6MbKc9_G8uQs_zLpTzr-06KjVa73xLhRu8bSGXmPY1yPnHnZCx0t4vTj8MP8KqUKUnTT2pXTuAv3MEpmVM1ATTbJl-CxcNohxqNU9rVsSfACU_5e9fNywUmGpohAcxOeoor_v6Dn3wzKWyFpuAcPOyzJBq3zH8EdXz-G-211ydUT-D5ufvsLdryyF5Vlo2rezInC4jwb1PRSpCGF5ves1S9esCawgV1h-5mpajby9flyxkzt2GnH63oKZ8NPP45P0q5-QmpzVSxT4UXwzplMKU0q7H3MluhJCC5iL42YasOtDRjzjXZO8MxgvKRX5dxlMphCimewUze13wfmVKD7uSC40fnUU3kyOjLiNhgpdbAJvFubrZy3Mhklphdk3vK2eRM4IpvetCFx6_ihuT4vu7VSFtIKf4i4zBaIJ4PVmDYFJRCbSetyLRM4WHuk7FbcotzMjwSet8656UVwkuTRRQJqy21bw9j-U1ezqLWtcoR8snjx_y7fwAOcjOXo8_jrS9jllJKTaq44gJ3l9S__CnHLcvo6Tsg_3sDqgA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Novel+Cyclic+Lipopeptide+Antibiotics%3A+Effects+of+Acyl+Chain+Length+and+Position&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Signe+Kaustrup+Jensen&rft.au=Thomas+T.+Thomsen&rft.au=Alberto+Oddo&rft.au=Henrik+Franzyk&rft.date=2020-08-13&rft.pub=MDPI+AG&rft.issn=1661-6596&rft.eissn=1422-0067&rft.volume=21&rft.issue=16&rft.spage=5829&rft_id=info:doi/10.3390%2Fijms21165829&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_86c3e1623c8540fc9217f735606cd496
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon